Nav: Home

New natural estrogen-progesterone capsule reduces postmenopausal hot flashes

April 03, 2017

ORLANDO -- A natural, or bioidentical, combined estradiol-progesterone capsule (TX-001HR) significantly decreases the frequency and severity of moderate to severe hot flashes in postmenopausal women, the Replenish study finds. Results of this phase 3, randomized, placebo-controlled, multicenter trial will be presented Monday at ENDO 2017, the Endocrine Society's 99th annual meeting in Orlando, Fla.

TX-001HR, an investigational oral hormone therapy developed by TherapeuticsMD Inc., which funded the study, underwent a year of testing in 1,835 postmenopausal women ages 40 to 65 years who had not had a hysterectomy. Data from a three-month substudy of 726 study participants with problematic postmenopausal vasomotor symptoms such as hot flashes (also called hot flushes) are being presented at the meeting.

"If approved, TX-001HR would be the first available combined natural estradiol-progesterone hormone therapy," said principal investigator Rogerio Lobo, M.D., professor of obstetrics and gynecology at Columbia University in New York, N.Y. "It may provide an alternative for treating hot flushes in postmenopausal women with an intact uterus, including an alternative for the estimated millions of women currently using unregulated, unapproved compounded hormonal preparations."

Compounded bioidentical hormones are custom-made at compounding pharmacies and are not regulated by the Food and Drug Administration (FDA). Yet, many women are choosing them over FDA-approved synthetic hormone therapies, possibly because they want natural, plant-derived hormones that are similar to those in the body, believing them to be safer. The FDA reports no evidence, however, that these compounded bioidentical products are safer than FDA-approved hormone therapies.

Lobo and co-investigators in the Replenish trial tested the safety and effectiveness of four doses of TX-001HR (natural 17-beta estradiol and natural progesterone) in a total of 1,835 women. In the substudy, 726 women who reported experiencing seven or more hot flashes per day due to menopause or at least 50 hot flashes a week were evaluated to assess the effect of TX-001HR specifically on treating hot flushes. These women were on average 54.6 years of age, and 67 percent were white. The women were randomly assigned to one of the TX-001HR doses or a placebo (an inert substance), without knowing which treatment they received.

The researchers reported that two doses of TX-001HR significantly improved both the frequency and severity of moderate to severe hot flashes by four weeks, and this benefit continued through 12 weeks compared with placebo. Those doses, Lobo reported, were 1 milligram (mg) of estradiol with 100 mg of progesterone daily or a daily combination of 0.5 mg estradiol and 100 mg of progesterone. In women with a uterus, progesterone is added to estrogen because estrogen alone raises the risk of cancer of the endometrium, the lining of the uterus.

Study participants showed no sign of thickening of the uterine lining, known as endometrial hyperplasia. Lobo stated that the women tolerated the drug well, with the most commonly reported side effects being headache, cold symptoms, breast tenderness and upper respiratory infection.
Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world's oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at Follow us on Twitter at @TheEndoSociety and @EndoMedia.

The Endocrine Society

Related Hot Flashes Articles:

Child abuse associated with physiologically detected hot flashes
Childhood abuse has been shown to lead to an array of health problems later in life.
Hot flashes shown to be linked to increased risk of later cardiovascular disease events
Previous studies suggested an association between hot flashes and cardiovascular (CVD) disease.
Persistent hot flashes may lead to increased risk of breast cancer
Studies examining the association between vasomotor symptoms (VMS) and breast cancer are not new, but results have been inconsistent.
Oxybutynin decreased frequency of hot flashes, improved QOL for breast cancer survivors
Treatment with oxybutynin helped reduce the frequency and intensity of hot flashes for women who could not take hormone replacement, including breast cancer survivors, according to results of a trial presented at the 2018 San Antonio Breast Cancer Symposium.
Pregnancy disorders may lead to more hot flashes
What occurs during pregnancy could have longer-term health effects than originally thought.
Scientists trigger hot flashes in female and male mice
By activating a single type of neuron, scientists triggered hot-flash-like symptoms in mice.
News flash about hot flashes: They can last longer than you think
Menopause symptoms are not just for midlife anymore, according to a new Mayo Clinic study published this month in the Journal of the North American Menopause Society.
Oral micronized progesterone may decrease perimenopausal hot flashes, night sweats
Oral micronized progesterone (OMP) may diminish hot flashes and night sweats in perimenopausal women, new research from Canada reports.
Sleep problems in menopause linked to hot flashes, depression -- and may not last
A new study of middle-aged women found that sleep problems vary across the stages of menopause, yet are consistently correlated with hot flashes and depression.
Study suggests hot flashes could be precursor to diabetes
Hot flashes, undoubtedly the most common symptom of menopause, are not just uncomfortable and inconvenient, but numerous studies demonstrate they may increase the risk of serious health problems, including heart disease.
More Hot Flashes News and Hot Flashes Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.